## TJX: The TJX Companies, Inc. - XLY: Consumer Cyclical

### Executive Summary

No thesis match: MRS_20 -0.4% below STRENGTH zone (4.0-10.0%); PEG 3.02 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge. Caution: momentum weakening (-4.7% MRS).

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($144.74)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_20 falling below -5% or breaking key support

### News

- **Articles:** 10
- **Sentiment:** Bullish (Bullish: 9, Bearish: 0)

**1. Will TJX Q3 Sales Momentum Continue as Marmaxx and HomeGoods Shine?**
- Source: TradingView | 20251203T193656 | Bullish | Relevance: 100%
- TJX Companies, Inc. (TJX) reported strong 5% consolidated comparable sales in Q3 fiscal 2026, driven by impressive performances in its Marmaxx apparel (6% growth) and HomeGoods (5% growth) divisions. The company's growth is attributed to higher customer transactions, increased average basket size, disciplined pricing, and broad-based category strength, suggesting sustained operating momentum. While Walmart (WMT) also saw solid comparable sales, and Burlington Stores (BURL) experienced a rebound in mid-October, TJX's price performance and valuation metrics appear favorable.

**2. Bernstein Boosts TJX Companies (TJX) Price Target Following Strong Quarterly Results**
- Source: Finviz | 20251203T013700 | Bullish | Relevance: 100%
- Bernstein SocGen Group raised its price target for TJX Companies to $155 from $152, maintaining an Outperform rating due to strong quarterly results. The firm highlighted TJX's effective off-price business strategy, which led to a 5% improvement in comparable sales and a 40 basis point increase in pre-tax profit margin. Bernstein expects further EPS outperformance from the company, recognized as a consistent strong performer in retail.

**3. Bernstein Boosts TJX Companies (TJX) Price Target Following Strong Quarterly Results**
- Source: Insider Monkey | 20251203T013700 | Bullish | Relevance: 100%
- Bernstein SocGen Group increased its price target for The TJX Companies, Inc. (NYSE:TJX) to $155 from $152, maintaining an Outperform rating due to strong quarterly results. The firm highlighted TJX's impressive 5% improvement in consolidated comparable sales and a 40 basis point increase in pre-tax profit margin, driven by its off-price business strategy and effective advertising. Bernstein expressed confidence in TJX's long-term prospects, expecting further EPS outperformance given its consistent strong performance in retail.

**4. TJX Stock (NYSE:TJX) in December 2025: Q3 FY26 Beat, New Analyst Price Targets and What Comes Next**
- Source: ts2.tech | 20251203T003057 | Bullish | Relevance: 100%
- TJX Companies (NYSE:TJX) is trading near all-time highs following a strong Q3 FY26 earnings beat and updated analyst price targets. The article details TJX's financial performance, institutional investor activity, updated guidance, and expansion plans. It also discusses the off-price giant's unique "anti-tech" business model, key risks, and Wall Street's consensus on its future prospects.

**5. TJX COMPANIES INC /DE/ SEC 10-Q Report**
- Source: TradingView | 20251202T170653 | Bullish | Relevance: 100%
- TJX Companies Inc. (TJX) released its Q3 fiscal 2026 10-Q report, showcasing strong financial performance with a 7% increase in net sales to $15,117 million and an 11% rise in net income to $1,442 million. The company's growth was driven by increased comparable store sales across its Marmaxx, HomeGoods, TJX Canada, and TJX International segments, with plans for continued store expansion and e-commerce enhancements. TJX also reported a decrease in cost of sales and increased store count, while anticipating $2.1 billion to $2.2 billion in capital expenditures for fiscal 2026.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 14, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-11-20 | UBS | $181 | $172 | +5% |
| 2025-11-20 | Citigroup | $168 | $160 | +5% |
| 2025-11-20 | Barclays | $168 | $155 | +8% |
| 2025-11-20 | JP Morgan | $154 | $150 | +3% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-11-20 | UBS | main | Buy |
| 2025-11-20 | Citigroup | main | Buy |
| 2025-11-20 | Barclays | main | Overweight |
| 2025-11-20 | JP Morgan | main | Overweight |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 0 ($0.00M) |
| Sells | 9 ($8.48M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 39.8% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 7 / 3 |

**Top Holders:**
- Vanguard Group Inc: 9.2% (+0.8%)
- Blackrock Inc.: 9.1% (+1.4%)
- State Street Corpora: 4.3% (-0.8%)
- JPMORGAN CHASE & CO: 3.5% (+80.3%)
- FMR, LLC: 3.0% (-0.7%)

### Key Risks

1. Insider selling cluster: $8.5M in recent transactions.
2. Valuation stretched: PEG 3.0x requires aggressive growth execution.
3. Market regime shift could impact momentum names disproportionately.

### Catalysts

- Analyst target momentum: 14 raises (avg +5%) could attract flows.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 3.02 signals overvaluation risk, limited margin of safety. Forward P/E 29.2x stretched relative to 10% growth. Quality metrics strong (ROE 58%, ROA 12%). Balance sheet: $1.0B free cash flow. Insider selling cluster ($8.5M in 90 days), potential headwind. Institutional flow bullish (7 buying vs 3 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $174.9B |
| Beta | 0.76 |
| 52W Range | $112.10 - $157.83 |
| Short Interest | 1.2% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 3.02 |
| Forward P/E | 29.2 |
| Current P/E | 32.1 |
| YoY Growth | 10.0% |
| EPS Direction | STABLE |

### Technicals

MRS_20 deteriorating from 4.3% to -0.4% (-4.7% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 4.4pp (needs >4.0% for momentum thesis). Full SMA alignment bullish (above 20/50/200 SMAs). RSI neutral at 58. OFD pattern: -SBL (Volatile).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | -0.38% (CS: 48) | Neutral |
| RSI_14 | 58.4 | Neutral |
| MACD Histogram | 0.13 | Bullish |
| vs SMA20 | 1.014x | Above |
| vs SMA50 | 1.038x | Above |
| vs SMA200 | 1.139x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $150.06
- **Stop Loss:** $144.74 (3.5% risk)
- **Target:** $155.38 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 214
- **Position Value:** $32,112.84
- **Portfolio %:** 32.11%
- **Risk Dollars:** $1,140.00
- **Risk Per Trade:** 1.14%
- **Modifiers:** L1 95% | L2 120% | Combined 1.14x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 0.95x |
| L2 Sector | TREND (Zone A) | 1.20x |

*NORMAL regime with moderately constructive conditions. Fed dovish pivot expectations from weak jobs data and declining VIX suggest improving risk appetite, though narrow breadth at 51% indicates selective participation. Focus on quality sectors benefiting from rate cut expectations.*

### Earnings

**Next:** 2026-02-25 (Est: $1.37)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q4 | $1.22 | $1.28 | +5.0% |
| 2025Q3 | $1.01 | $1.10 | +8.5% |
| 2025Q2 | $0.91 | $0.92 | +0.8% |
| 2025Q1 | $1.17 | $1.23 | +5.3% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_20*